Skip to main content

An official website of the United States government

You have 2 new alerts

PREVENT Cancer Preclinical Drug Development Program

Award Details

  • Contract Award Date: Mar 28, 2023
  • Contract Award Number: Attached
  • Task/Delivery Order Number:
  • Modification Number:
  • Contractor Awarded Unique Entity ID:

General Information

  • Contract Opportunity Type: Justification (Original)
  • Original Published Date: Apr 06, 2023 08:02 am EDT
  • Inactive Policy: 30 days after published date
  • Original Inactive Date:
  • Authority: FAR 6.302-1 - Only one responsible source (except brand name)
  • Initiative:
    • None

Classification

  • Product Service Code: AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:

Description

See attached for a copy of the Justification and Approval document to increase the stated maximum dollar value (programmatic ceiling) for the following contracts: 75N91019D00012, 75N91019D00013, 75N91019D00014, 75N91019D00015, 75N91019D00016, 75N91019D00017, 75N91019D00018, 75N91019D00020, 75N91019D00021, 75N91019D00022, 75N91019D00025, and 75N91019D00026.

Contact Information

Contracting Office Address

  • OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
  • Bethesda , MD 20892
  • USA

Primary Point of Contact

Secondary Point of Contact





History

  • May 06, 2023 11:59 pm EDTJustification (Original)